Use QbD to Get Through Rough Patch, FDA Tells Transdermal Makers
This article was originally published in The Gold Sheet
Executive Summary
FDA officials say that there are “scientific gaps” in how transdermal patches are developed, manufactured and regulated, and urged manufacturers to adopt quality- by-design methods to help bridge these gaps and to better ensure product quality and safety.